Cited by 164Liver physiology and pathologyTissue Engineering and Regenerative Medicine3D Printing in Biomedical Research

Organoids to model liver disease

Open access
Nuciforo, Sandro, Heim, Markus H.·2021·JHEP Reports

Abstract

The organoid model represents a major breakthrough in cell biology that has revolutionised biomedical research. Organoids are 3D physiological in vitro structures that recapitulate morphological and functional features of in vivo tissues and offer significant advantages over traditional cell culture methods. Liver organoids are of particular interest because of the pleiotropy of functions exerted by the human liver, their utility to model different liver diseases, and their potential application as cell-based therapies in regenerative medicine. Moreover, because they can be derived from patient tissues, organoid models offer new perspectives in personalised medicine and drug discovery. In this review, we discuss the current liver organoid models for the study of liver disease.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jhepr.2020.100198

Cites

103 of 103 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • 3D liver organoid systems better preserve cell identity and enable longer-term propagation compared with traditional 2D models while also supporting patient-specific disease modeling and drug testing.

    “Among the most impactful advances has been the rise of 3D liver organoid systems, which better preserve cell identity and enable longer-term propagation compared with traditional 2D models while also supporting patient-specific disease modeling and drug testing approaches [40,41].”

    From The Hepatocyte Expansion Paradox: A Review of In Vitro Challenges and Advances (2026) · cites this paper as [40]

    The Introduction and Table 1 describe long-term expansion of some liver organoids, and the Future perspectives section supports patient-derived disease modeling and drug testing (page numbers unavailable). The comparison with traditional 2D models is too broad: Table 1 rates cancer cell lines as highly maintainable, while the Adult-derived liver organoids section says primary human hepatocytes retain a more mature phenotype than hepatocyte organoids and notes that adult-derived organoids have limited expansion. (LLM, conf=0.85)

    Experimental — accuracy not yet measured
  • PSC-derived hepatocyte-like cells generally show lower functional recapitulation than primary hepatocytes, and most fail to self-renew post-differentiation, requiring repeated rounds of de novo differentiation.

    “PSC-derived hepatocyte-like cells illustrate this well; they generally show lower functional recapitulation than PHs, and most fail to self-renew post-differentiation, requiring repeated rounds of de novo differentiation that constrain their direct substitutability with adult hepatocyte systems [40].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

3 of the 106 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Nuciforo, S., & Heim, M. H.
Affiliations
University of Basel (CH)
Corresponding author
Heim, Markus H.
Venue
JHEP Reports
Publisher
Elsevier BV
Published
2021-02
Volume
3
Issue
1
Pages
100198
ISSN
2589-5559 (ISSN-L)
OpenAlex
W3094299399
Cited by
164
References
106
Citations by year
2026: 16 · 2025: 30 · 2024: 40 · 2023: 31 · 2022: 27 · 2021: 19
FWCI
2.57
Type
journal article
Language
en
Open access
Locations
  • JHEP Reports (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • SystemsX.ch
  • Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
  • European Research Council
Topics
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
liver organoids, liver disease modeling, organoid culture, regenerative medicine, cell therapy, personalized medicine, drug discovery, patient-derived tissue

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review